Table 1.
CLINICAL CHARACTERISTICS OF PATIENT POPULATION AND PRIMARY TUMOR SITES (*P<0.05).
| Characteristics | OMS patients | HNM patients |
|---|---|---|
| Total, n (%) | 596 (87.65%) | 84 (12.35%) |
|
| ||
| Gender (M), n (%) | 307 (51.51%) | 56 (66.67%)* |
|
| ||
| Age (y) | ||
| Mean | 53.54 | 57.75 |
| Median | 54.20 | 59.36 |
| Range | 9.72 – 88.90 | 13.92 – 95.03 |
|
| ||
| Breslow thickness, n (%) | ||
| ≤2 mm | 448 (75.17%) | 59 (70.24%) |
| 2–4 mm | 81 (13.59%) | 10 (11.90%) |
| ≤4 mm | 67 (11.24%) | 15 (17.90%) |
|
| ||
| Clark level | ||
| I | 8 (1.34%) | 0 |
| II | 57 (9.56%) | 5 (5.95%) |
| III | 110 (18.46%) | 15 (17.86%) |
| IV | 190 (31.88%) | 30 (35.71%) |
| V | 25 (4.19%) | 7 (8.33%) |
| Unknown | 206 (34.56%) | 27 (32.14%) |
|
| ||
| Ulceration, n (%) | ||
| Absent | 414 (69.46%) | 56 (66.67%) |
| Present | 132 (22.15%) | 20 (23.81%) |
| Unknown | 50 (8.39%) | 8 (9.52%) |
|
| ||
| Positive SLNs, n (%) | 138 (23.15%) | 15 (17.86%) |
|
| ||
| Histological subtype | ||
| Superficial spreading | 281 (47.15%) | 36 (42.86%) |
| Nodular | 113 (18.96%) | 18 (21.43%) |
| Lentigo maligna | 2 (0.34%) | 12 (14.29%)* |
| Acrale | 4 (0.67%) | 0 |
| Spitzoid | 7 (1.17%) | 0 |
| Others | 4 (0.67%) | 0 |
| Not otherwise specified | 185 (31.04%) | 16 (19.05%) |